Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

23.53EUR
21 Jul 2017
Change (% chg)

€-0.22 (-0.95%)
Prev Close
€23.75
Open
€23.69
Day's High
€23.80
Day's Low
€23.42
Volume
375,159
Avg. Vol
736,093
52-wk High
€26.97
52-wk Low
€16.48

Select another date:

Wed, Jul 5 2017

BRIEF-Grifols buys 44 pct stake in GigaGen for $35 mln

* SAYS BUYS 43.96 PERCENT SHAREHOLDING IN GIGAGEN INC FOR $35 MILLION

BRIEF-Faes Farma closes purchase of Laboratorios Diafarm

* CLOSES PURCHASE OF LABORATORIOS DIAFARM FOR 70 MILLION EUROS

BRIEF-Grifols' unit to initiate phase II clinical trials of Alzheimer's vaccine

* SAYS ITS UNIT ARACLON BIOTECH RECEIVES APPROVAL TO INITIATE PHASE II CLINICAL TRIALS OF ITS ALZHEIMER'S VACCINE Source text for Eikon:

BRIEF-Grifols enters into exclusive long-term distribution deal with Beckman Coulter

* SAYS ENTERS INTO AN EXCLUSIVE LONG TERM DISTRIBUTION AGREEMENT WITH BECKMAN COULTER

BRIEF-Grifols to exclusively supply plasma derived products to US Ethicon inc‍​

* SAYS SIGNS AGREEMENT TO EXCLUSIVELY MANUFACTURE AND SUPPLY PLASMA DERIVED PRODUCTS FOR THE BIOSURGERY FIELD TO ETHICON INC‍​

BRIEF-Grifols proposes dividend of 0.11 eur/shr net

* PROPOSES DIVIDEND OF 0.11 EURO PER SHARE NET TO BE PAID ON JUNE 1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Grifols Q1 net profit up 7 pct YoY

* Q1 net profit 134.0 million euros ($146.3 million) versus 125.2 million euros year ago

BRIEF-Reig Jofre to produce biotech vaccine for Laboratorios Leti

* To produce for Laboratorios Leti biotech vaccine developed from protein Q, which Laboratorios Leti plans to commercialize internationally

BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies

* Grifols - announces that it has restated its 2005 agreement with Orasure Technologies

BRIEF-Grifols closes 1.00 bln euro bond issue, completes debt refinance process

* Says closes 1.00 billion euro ($1.07 billion)issue of senior unsecured bonds due May 1st 2025, with annual coupon of 3,20 percent

Select another date: